Watch VideoAstrazeneca has resumed phase 3 trials for its COVID-19 vaccine.
The trial stopped last month after one of the volunteers had a serious reaction.
Health officials told Newsy that the pause was "completely appropriate." They said they hope this boosts confidence that Operation Warp Speed isn't just about speed,...
Astrazeneca Resumes Phase 3 Coronavirus Vaccine Trial
Newsy
0 shares
1 views
You might like
Related news coverage
NA Proactive news snapshot: Medexus Pharmaceuticals, Next Green Wave, Humanigen, Canada Silver Cobalt Works, American Resources UPDATE...
Proactive Investors
Medexus Pharmaceuticals Inc (CVE:MDP) (OTCQX:MEDXF) revealed that it has struck an agreement with Geneva, Switzerland-based..
-
NA Proactive news snapshot: American Resources, MagicMed Industries, AIM ImmunoTech, Water Tower Research, Genprex UPDATE ...
Proactive Investors
-
COVID-19 vaccine: Infections reported among Sputnik V trial volunteers
Mid-Day
-
NA Proactive news snapshot: CleanSpark, XPhyto Therapeutics, GGX Gold, Altamira Gold, Goldseek Resources, Mawson Gold, UPDATE …
Proactive Investors
-
NA Proactive news snapshot: CleanSpark, Newrange Gold, XPhyto Therapeutics, GGX Gold, Altamira Gold, Goldseek Resources UPDATE …
Proactive Investors
Advertisement
More coverage
Dangers Of Jumping The Gun On A COVID-19 Vaccine – Analysis
Eurasia Review
By Hannah Clapham*
With COVID-19 cases still rising globally, the race is on for a vaccine. Pressures are mounting to..
-
NA Proactive news snapshot: XPhyto Therapeutics, GGX Gold, Altamira Gold, Goldseek Resources, Mawson Gold, Innocan Pharma UPDATE…
Proactive Investors
-
NA Proactive news snapshot: Mawson Gold, Innocan Pharma, District Metals, XPhyto Therapeutics …
Proactive Investors
-
Sanofi, GSK to provide COVID-19 vaccine to global alliance
SeattlePI.com
-
States urged to adopt national approach: Niti Aayog on 'free vaccine'
Mid-Day